Gross Profit On Sales 更改
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amgen USD 5.08B 14M 2023-12
BioCryst Pharmaceuticals USD 85.61M 4.06M 2023-09
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bluebird Bio USD 1.44M 4.11M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Eli Lilly USD 7.57B 73.1M 2023-12
Exelixis USD 453.15M 1M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
Incyte USD 949.29M 84.66M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Merck USD 11.29B 441M 2023-12
Moderna USD 1.88B 2.29B 2023-12
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Incyte 销售毛利 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.